The transit police officer who survived a showdown with the …
Newport woman among the many victims returning to the city for …
Gov. Deval Patrick and his wife, Diane, are grandparents for …
Updated: Sunday, 11 Nov 2012, 7:49 PM EST
Published : Sunday, 11 Nov 2012, 5:18 PM EST
BOSTON (AP) -- The state's oversight of compounding pharmacies will be the subject of a legislative hearing.
Massachusetts lawmakers called for the Statehouse hearing on Wednesday in the wake of a nationwide fungal meningitis outbreak linked to a steroid distributed by Framingham-based New England Compounding Center.
The outbreak has sickened more than 400 people and caused more than 30 deaths.
The state pharmacy board is under scrutiny for its handling of past complaints against the company. The board's director, James Coffey, was fired last week.
The Massachusetts board falls under the umbrella of the state Department of Public Health. The agency also faces questions about its oversight of a now-closed state lab, where a former chemist has been accused of mishandling drug tests.
Ground rules for posting comments: No profanity or personal attacks. Please comment on the subject of the story itself. If you do not follow these rules, we will remove your post. Keep it civil, folks!
Our commenting section is powered by IntenseDebate. If you registered for an account but didn't receive a verification e-mail, check your spam folder or click here for more information. For additional technical help, click here.